anthranilamide has been researched along with Friedreich Ataxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottesfeld, JM; Shan, B; Xu, C; Xu, T; Yates, JR; Zhang, Y | 1 |
| Gottesfeld, JM; Jacques, V; Plasterer, HL; Rusche, JR; Soragni, E; Xu, C | 1 |
1 review(s) available for anthranilamide and Friedreich Ataxia
| Article | Year |
|---|---|
Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia.
Topics: Animals; Clinical Trials, Phase I as Topic; Disease Models, Animal; Fluorescent Dyes; Frataxin; Friedreich Ataxia; Gene Expression Regulation; Histone Deacetylase Inhibitors; Humans; Iron-Binding Proteins; Mice; Mutation; ortho-Aminobenzoates; Proteomics; Trinucleotide Repeat Expansion | 2012 |
1 other study(ies) available for anthranilamide and Friedreich Ataxia
| Article | Year |
|---|---|
Quantitative proteomic analysis identifies targets and pathways of a 2-aminobenzamide HDAC inhibitor in Friedreich's ataxia patient iPSC-derived neural stem cells.
Topics: Friedreich Ataxia; Histone Deacetylase Inhibitors; Humans; Induced Pluripotent Stem Cells; Mass Spectrometry; Molecular Probes; Neural Stem Cells; Nuclear Proteins; ortho-Aminobenzoates; Proteomics; Pyrazoles; Pyridinium Compounds; RNA Processing, Post-Transcriptional | 2014 |